APL-5125 for advanced solid tumors (AP10CP01)
Clinical Trial Grant
Awarded By
Apollo Therapeutics
Start Date
September 6, 2024
End Date
September 9, 2029
Awarded By
Apollo Therapeutics
Start Date
September 6, 2024
End Date
September 9, 2029